Golden Seeds joins $6.4M financing round for therapeutic combating ulcerative colitis
A pharmaceutical startup gearing up for clinical trials for its antibody targeting digestive maladies has raised $6.4 million in a Series B financing round. Golden Seeds, an angel investment group that typically allocates funds to life science companies led by women entrepreneurs, co-led the financing round. Barbara Fox is the CEO of the seven year […]